Device Trials Hit With Warning Letters

Clinical Trials Advisor
Two clinical investigators and a sponsor of device trials received FDA warning letters in three separate and unrelated inspections involving failure to carry out required procedures, inadequate recordkeeping and reporting failures.

To View This Article:


Subscribe To Clinical Trials Advisor

Buy This Article Now

Add this article to your cart for $10.00